PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532800
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532800
Biomaterial Testing Equipment Market size was valued at USD 3,290.32 Million in 2023, expanding at a CAGR of 7.90% from 2024 to 2032.
Biomaterials testing equipment is utilized for the mechanical testing of biomaterials, artificial biological products, and specific medical devices, including bone, soft tissues such as skin, muscle, or arteries, engineered tissues, and scaffolds for implantation. Biomaterial testing encompasses a wide range of tests, from simple tensile, compression, or flexure tests to thorough material characterization and complex planar biaxial evaluations. It is crucial to ensure that implants like stents, joint replacements, and dental implants meet the necessary standards, as well as evaluate scaffolds and matrices for cell growth and tissue regeneration.
Biomaterial Testing Equipment Market- Market Dynamics
The expansion of the worldwide healthcare sector and progress in biomaterial technology are anticipated to propel market growth.
The healthcare infrastructure is experiencing increased investments from both government and private sectors, resulting in a higher demand for advanced medical devices and materials. The healthcare sector is a significant and intricate part of the U.S. economy, representing 18% of the gross domestic product (GDP) in 2020, as reported by Investopedia. Progress in biomaterial science is driving the creation of new and improved materials with enhanced properties, including biocompatibility, strength, and durability. Additionally, technological advancements in testing equipment could present growth opportunities for the market. However, the high cost of testing equipment may impede market growth.
Biomaterial Testing Equipment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.90% over the forecast period (2024-2032)
Based on Material Type segmentation, Metallic materials was predicted to show maximum market share in the year 2023
Based on region, North America was the leading revenue generator in 2023
The Global Biomaterial Testing Equipment Market is segmented based on Product Type, Material type, Application, and Region.
The market is categorized into four groups according to Product Type: Tensile Testing Machine, Torque Testing Machine, Fatigue Testing Machine, and Flexure Testing Machine. The biomaterial testing equipment market can be divided into different types of testing machines, each tailored to assess specific properties of biomaterials.
The market is segmented into four groups according to Material type: Ceramic, Metallic, Natural, and Polymers. Metallic materials hold the largest share in the market. Metallic biomaterials are widely utilized in a range of medical applications because of their superior mechanical characteristics, biocompatibility, and longevity.
The market is segmented into four categories according to Application: Mechanical, Biomedical, Materials Engineering, Textile Industry, and Others. Each application has distinct testing equipment requirements to guarantee the performance, safety, and reliability of biomaterials.
Biomaterial Testing Equipment Market- Geographical Insights
This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Each of these regions is further divided by nation, contributing to business growth. North America leads the market, driven by the increasing demand for medical implants and devices. The growing elderly population in North America is fueling the need for medical implants such as joint replacements, cardiovascular devices, and dental implants. As the population ages, the prevalence of conditions requiring these implants, such as osteoarthritis and cardiovascular diseases, is on the rise. According to the American College of Rheumatology, about 790,000 total knee replacements and 544,000 hip replacements are performed annually in the U.S., and this number continues to increase as the population ages. Europe is the second largest region for market growth, attributed to its well-established healthcare infrastructure.
The competitive environment of the biomaterial testing equipment market is characterized by the involvement of different global and regional companies. These firms compete for a share of the market by focusing on product innovation, technological progress, quality, pricing, and customer service. The ongoing innovation aims to offer testing equipment that is more precise, efficient, and user-friendly. Automation, high-throughput screening, and real-time data analysis are significant advancements. A key growth strategy involves expanding into emerging markets, particularly in the Asia-Pacific region, where the healthcare infrastructure is rapidly evolving. Companies are establishing local offices and service centers to better serve these markets.
Instron is pleased to introduce the latest Autoinjector Testing System for comprehensive testing of pen and autoinjectors to ISO 11608. Created in collaboration with pharmaceutical companies and CDMOs, this system evaluates a range of critical performance criteria, such as cap removal, dose accuracy, activation force, injection time, needle depth, and needle guard lockout.
AMETEK Scientific Instruments, a prominent provider of global technology solutions, is enhancing its range of battery cyclers by launching the AMETEK Solartron Analytical's SI-6200 Battery Analyzer. This advanced and feature-rich analyzer is not only cost-effective but also provides solutions for the early-stage testing of battery materials, coin cells, supercapacitors, and micro fuel cells.
GLOBAL BIOMATERIAL TESTING EQUIPMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Zwick Roell
CellScale
Instron
Mts Systems
Shimadzu
Tinius Olsen
Ametek
Admet
Hegewald & Peschke
Applied Test Systems
Mitutoyo
Ta Instruments
Torontech
Qualitest International
Ets Intarlaken
Struers
Others